DIDAX 60mg MR gliclazide 60 mg modified release tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

gliclazide, Quantity: 60 mg

Saadav alates:

Servier Laboratories (Aust) Pty Ltd

INN (Rahvusvaheline Nimetus):

Gliclazide

Ravimvorm:

Tablet, modified release

Koostis:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maltodextrin; hypromellose; colloidal anhydrous silica

Manustamisviis:

Oral

Ühikuid pakis:

20, 60

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Type II Diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Toote kokkuvõte:

Visual Identification: White oblong tablets. Break bar. DIA 60 on both faces; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2015-12-02